SEC Form 4 Summary LGND

LGND director Martine Zimmermann reports $636,336.20 share sale

Ligand Pharmaceuticals director Martine Zimmermann sold 2,000 LGND shares for $636,336.20 in one transaction on November 12, 2026.

Transaction Value:
$636,336.20
Shares transacted:
2,000
Average price:
$318.17
Insider:

The Form 4 filing, an SEC report of insider stock trades, was filed on November 16, 2026. The sale took place on November 12, four days before the filing date.

The report lists Martine Zimmermann as a director of Ligand Pharmaceuticals (LGND). The company is in the healthcare sector's biotechnology industry.

Transaction details

Transaction
Date of Earliest Transaction2026-11-12
Date of Latest Transaction2026-11-12
Buy/Sellsell
Transaction Count1
Shares Transacted2,000
Price$318.17
Total Transaction Value$636,336.20
Insider
Ticker SymbolLGND
CompanyLIGAND PHARMACEUTICALS INC
Insider NameZimmermann Martine
Insider TitleDirector
Sector - IndustryHealthcare - Biotechnology
Holdings
Total Shares Owned After Transaction1,782
Position Size Change52.88%
Filing
Filing Date2026-11-16
SEC LinkView filing

FAQ

What type of transaction is this?

This was a sale of 2,000 LGND shares, reported under transaction code S. The record lists one transaction by Martine Zimmermann.

What was the average price of the transaction?

The average sale price was $318.1681 per share. Rounded to cents, that is $318.17 per share.

How did this transaction affect the insider's holdings?

Martine Zimmermann sold 2,000 shares and reported 1,782 shares owned afterward. The sale represented 52.88% of the shares held before the trade, based on this reported balance. Shares remained in that balance after the sale.

What's the total transaction value?

The total transaction value was $636,336.20. That amount covers the single reported sale of 2,000 shares.

Are there any special circumstances around this transaction?

The available transaction information did not identify a special arrangement. Footnote text was not provided, so further details about the sale's terms and circumstances remain unknown.

For research purposes only; not investment advice.

Follow the Newswire
Feedly RSS feed
About RSS

Get new articles in your feed reader as they are published. Add our RSS feed to Feedly or another RSS reader.

Instant SEC Form 4 alerts

Get the next insider trade alert in real time.

Follow the filings behind the headlines. Get matching insider trade alerts sent straight to your email or Telegram, with links to the original SEC filings. Choose Premium for instant alert delivery and ticker-level filters.

Try instant alerts free 10 trading days · No credit card required

Pricing

Free Trial

10 trading days
$0

Explore every Premium feature before you pay.

  • Full platform access
  • 10 trading days
  • No credit card required
  • 20 years of alert history
  • Live alert directory updates
Start your free trial

Standard Monthly

Scheduled
$19.99 / month

Scheduled alerts with complete trade context.

  • Email and Telegram delivery
  • Alert intervals from every sixty minutes to once daily
  • Filter by insider title, buy/sell, transaction value, DRIP, ESPP, 10b5-1, and tax liability coverage transfers
  • Highlighted cluster transactions and SEC filing links
  • Access to the alert directory hourly refreshes
Choose Standard Monthly

Premium Monthly

Recommended
$29.99 / month

Fastest alerts with ticker-level control.

  • Everything in Standard
  • Instant delivery detection-to-outbound time averages 0.60 seconds
  • Alert intervals starting from one minute
  • Real time alert directory updates
Choose Premium Monthly
Student discount: Customers who sign up with a verified .edu email address receive 50% off for the first four years. On monthly plans, the first month is the full 75% off.
Alerts are based on public SEC filings and are provided for informational purposes only; they do not constitute financial advice.